Atomistry » Bromine » PDB 4d4j-4g6v » 4d4m
Atomistry »
  Bromine »
    PDB 4d4j-4g6v »
      4d4m »

Bromine in PDB 4d4m: Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound

Enzymatic activity of Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound

All present enzymatic activity of Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound:
2.7.1.105; 3.1.3.46;

Protein crystallography data

The structure of Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound, PDB code: 4d4m was solved by S.A.Stgallay, N.Bennett, S.Critchlow, G.Davies, J.E.Debreczeni, N.Evans, G.Holdgate, N.P.Jones, L.Leach, S.Maman, S.Mcloughlin, M.Preston, L.Rigoreau, A.Thomas, G.Walker, J.Walsch, R.A.Ward, E.Wheatley, J.Winter, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 73.16 / 2.32
Space group P 65 2 2
Cell size a, b, c (Å), α, β, γ (°) 102.620, 102.620, 257.660, 90.00, 90.00, 120.00
R / Rfree (%) 19.14 / 20.89

Bromine Binding Sites:

The binding sites of Bromine atom in the Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound (pdb code 4d4m). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound, PDB code: 4d4m:

Bromine binding site 1 out of 1 in 4d4m

Go back to Bromine Binding Sites List in 4d4m
Bromine binding site 1 out of 1 in the Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Human PFKFB3 in Complex with A Pyrrolopyrimidone Compound within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br1449

b:61.8
occ:1.00
BR A:BKV1449 0.0 61.8 1.0
C15 A:BKV1449 1.9 58.8 1.0
C16 A:BKV1449 2.8 53.9 1.0
C14 A:BKV1449 2.8 58.0 1.0
O A:LEU238 2.9 47.0 1.0
O A:HOH2165 3.7 56.3 1.0
CG1 A:VAL214 3.8 47.1 1.0
CG1 A:ILE241 3.8 45.3 1.0
C A:LEU238 3.8 47.5 1.0
CD1 A:ILE241 4.0 50.3 1.0
CA A:LEU238 4.1 44.8 1.0
C17 A:BKV1449 4.1 53.7 1.0
C13 A:BKV1449 4.1 57.7 1.0
CB A:LEU238 4.2 45.8 1.0
CA A:GLY218 4.2 49.3 1.0
CD2 A:LEU238 4.3 53.4 1.0
CE2 A:PHE221 4.4 46.4 1.0
CZ A:PHE221 4.5 45.6 1.0
N A:GLY218 4.6 50.5 1.0
O A:ILE241 4.6 49.0 1.0
C12 A:BKV1449 4.7 54.3 1.0
CG2 A:VAL214 4.7 46.5 1.0
CG A:LEU238 4.9 50.8 1.0
C A:VAL217 4.9 53.1 1.0
O A:VAL217 4.9 51.5 1.0
CB A:VAL214 4.9 47.4 1.0

Reference:

S.A.Stgallay, N.Bennett, S.Critchlow, G.Davies, J.E.Debreczeni, N.Evans, G.Holdgate, N.P.Jones, L.Leach, S.Maman, S.Mcloughlin, M.Preston, L.Rigoreau, A.Thomas, G.Walker, J.Walsch, R.A.Ward, E.Wheatley, J.Winter. Identifying A Novel Series of PFKFB3 Inhibitors As A Metabolic Approach to Treating Cancer From Hts, Biophysical and Biochemical Methods To Be Published.
Page generated: Wed Jul 10 21:06:23 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy